Barr Pharmaceuticals(BRL) said Thursday that it has received permission to begin marketing Seasonique, an oral contraceptive that reduces the number of women's menstrual periods to quarterly from monthly.
The Food and Drug Administration approved the product, which will become the eventual successor to Seasonale, another so-called extended cycle contraceptive that also reduces periods to quarterly from monthly. Seasonique should be available in July. Seasonale loses patent protection in September. Watson Pharmaceuticals(WPI) has received tentative approval from the FDA to market a generic version pending expiration of the patent. Barr's announcement, which came shortly before markets closed, helped raise the stock $1.13, or 2.2%, to a closing price of $53.75. The Seasonique application received conditional approval in August 2005. Although an FDA ruling had been expected in March, the agency asked for more time to review the application and the company's proposed labeling.>To order reprints of this article, click here: ReprintsTheStreet Premium Services For Personal Service: 877-471-2967
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
ETF Profits:
Get money-making ideas from the hottest investment vehicle on the planet. Our experts show you how to play various ETF sectors to help pump-up your portfolio. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 12,842.10 | 1,350.45 | 2,920.89 | 19.74 |
Oil *
117.86
|
|
UP
40.87 |
UP
7.81 |
UP
17.01 |
UP
0.05 |
10 Yr
1.97%
SPDR Gold
167.10
|
|
+0.32%
|
+0.58%
|
+0.59%
|
+0.25%
|
Data delayed 20 minutes |
Connect with TheStreet